| Agea Challa Temesgen, | |
|
9715 Liberia Ave, Manassas, VA 20110-5837 | |
| (571) 229-1797 | |
| Not Available |
| Full Name | Agea Challa Temesgen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 9715 Liberia Ave, Manassas, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043931694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 0024184934 (Virginia) | Primary |
| Entity Name | Patient First Richmond Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689603748 PECOS PAC ID: 9931011434 Enrollment ID: O20031103000500 |
News Archive
Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme's efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant's operation for an extended period and certify compliance with FDA regulations.
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.
The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.
Scientists have puzzled over just why organisms evolved aging as a strategy, and now there appears to be an answer. Allowing one individual to carry all the cellular damage inflicted over time, rather than dividing it between two organisms during reproduction, increases the chances that the individual's line will continue to reproduce for many generations to come, a new study indicates.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Agea Challa Temesgen, 5000 Cox Rd, Glen Allen, VA 23060-9263 Ph: (804) 822-4355 | Agea Challa Temesgen, 9715 Liberia Ave, Manassas, VA 20110-5837 Ph: (571) 229-1797 |
News Archive
Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme's efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant's operation for an extended period and certify compliance with FDA regulations.
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.
The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.
Scientists have puzzled over just why organisms evolved aging as a strategy, and now there appears to be an answer. Allowing one individual to carry all the cellular damage inflicted over time, rather than dividing it between two organisms during reproduction, increases the chances that the individual's line will continue to reproduce for many generations to come, a new study indicates.
› Verified 1 days ago
Susan Brien Campbell, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8700 Sudley Rd, Manassas, VA 20110 Phone: 703-396-5292 Fax: 703-396-5297 | |
Shraddha Lamichhane, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10892 Caraway Cir, Manassas, VA 20109 Phone: 703-980-2783 | |
Helen Karellas Bardis, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9430 Forestwood Ln, Suite 100, Manassas, VA 20110 Phone: 703-365-0227 | |
Deepika Shrestha Rajbhandary, FNP BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6360 Hoadly Rd, Manassas, VA 20112 Phone: 703-897-4961 | |
Shenise Seabrook, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6909 Stethem Ct, Manassas, VA 20112 Phone: 843-452-9746 | |
Stephanie E Song, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8644 Sudley Rd Ste 114, Manassas, VA 20110 Phone: 703-330-4500 |